Skip to main content

Peer Review reports

From: Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis

Original Submission
17 Oct 2022 Submitted Original manuscript
26 Dec 2022 Reviewed Reviewer Report - Qiancheng Hu
8 Jan 2023 Reviewed Reviewer Report
18 Feb 2023 Author responded Author comments - Alessandro Parisi
23 Feb 2023 Author responded Author comments - Alessandro Parisi
Resubmission - Version 2
18 Feb 2023 Submitted Manuscript version 2
19 Mar 2023 Reviewed Reviewer Report - Qiancheng Hu
20 Mar 2023 Reviewed Reviewer Report
23 Mar 2023 Author responded Author comments - Alessandro Parisi
Resubmission - Version 3
23 Mar 2023 Submitted Manuscript version 3
25 Mar 2023 Author responded Author comments - Alessandro Parisi
Resubmission - Version 4
25 Mar 2023 Submitted Manuscript version 4
28 Mar 2023 Author responded Author comments - Alessandro Parisi
Resubmission - Version 5
28 Mar 2023 Submitted Manuscript version 5
14 May 2023 Reviewed Reviewer Report - Qiancheng Hu
20 May 2023 Author responded Author comments - Alessandro Parisi
Resubmission - Version 6
20 May 2023 Submitted Manuscript version 6
28 May 2023 Reviewed Reviewer Report - Qiancheng Hu
8 Jun 2023 Author responded Author comments - Alessandro Parisi
Resubmission - Version 7
8 Jun 2023 Submitted Manuscript version 7
Publishing
13 Jun 2023 Editorially accepted
19 Jun 2023 Article published 10.1186/s12876-023-02853-w

You can find further information about peer review here.

Back to article page